The Regulatory Center

Filter Your Results

 

News

 

Medtronic's Micra Pacing System Receives CMS Coverage

March 10, 2017 -- Medtronic announced that the US Centers for Medicare & Medicaid Services (CMS) have approved coverage for the company's Micra transcatheter pacing sy…

Boston Scientific Voluntarily Recalls All Lotus TAVR Devices

February 23, 2017 -- In a Form 8-K report to the US Securities and Exchange Commission (SEC), Boston Scientific announced a voluntary removal of all Lotus transcathe…

Abbott Set to Close Acquisition of St. Jude Medical, Inc.

January 3, 2017 -- Abbott Vascular announced last week that it intends to close the acquisition of St. Jude Medical, Inc. on Wednesday, January 4. The announcement follows the…

Cardinal Health Announces Strategic Distribution Agreements in International Markets

October 31, 2016 -- Cardinal Health announced several new strategic distribution agreements that will enable Cordis, Cardinal Health’s interventional vascular business, …

Abbott and St. Jude to Sell Portion of Vascular Closure and Electrophysiology Businesses to Terumo

October 18, 2016 -- Abbott Vascular and St. Jude Medical, Inc. announced an agreement in principle to sell certain products to Terumo Corporation. The transaction reflects a p…

SCAI Responds to CMS Regarding Proposed AMI Bundles

October 3, 2016 -- The Society for Cardiovascular Angiography and Interventions (SCAI) announced it has recently submitted comments to the Centers for Medicare & Medi…

FDA Classifies Two Field Actions Related to Medtronic’s HeartWare HVAD System as Class 1 Recalls

September 30, 2016 -- Medtronic plc announced today that two previously communicated global voluntary recalls related to the HeartWare International HVAD system, a full-suppor…

Abiomed’s Impella 2.5 and Impella 5.0 Heart Pumps Approved in Japan

September 27, 2016 -- Abiomed, Inc. announced that the company’s Impella 2.5 and Impella 5.0 heart pumps received Pharmaceuticals and Medical Devices Agency (PMDA) appro…

 

advertisement

2017 Buyer’s Guide

This Buyer’s Guide offers a searchable, comprehensive listing of the FDA-approved interventional devices available in the United States.

 
 

Contact Info

For advertising rates and opportunities, contact:
Craig McChesney
484-581-1816
cmcchesney@bmctoday.com

Stephen Hoerst
484-581-1817
shoerst@bmctoday.com

Charles Philip
484-581-1873
cphillip@bmctoday.com

About Cardiac Interventions Today

Cardiac Interventions Today is a publication dedicated to providing comprehensive coverage of the latest developments in technology, techniques, clinical studies, and regulatory and reimbursement issues in the field of coronary and cardiac interventions. Cardiac Interventions Today premiered in March 2007, with its launch issue focusing on the state of coronary drug-eluting stent use. Each edition will cover a variety of topics in a flexible format that includes articles covering various perspectives on current clinical topics, in-depth interviews with expert physicians, overviews of available technologies, industry news, and insights into the issues affecting today's cardiology practices.